Cart
sales@molnova.com
BGP-15
CAS No. 66611-37-8
BGP-15( BGP 15 | BGP15 )
Catalog No. M15540 CAS No. 66611-37-8
A PARP inhibitor and an inducer of HSF-1/HSP72 (cotreatment with heat) in vtiro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 431 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBGP-15
-
NoteResearch use only, not for human use.
-
Brief DescriptionA PARP inhibitor and an inducer of HSF-1/HSP72 (cotreatment with heat) in vtiro.
-
DescriptionA PARP inhibitor and an inducer of HSF-1/HSP72 (cotreatment with heat) in vtiro; has no effect on HSP90 levels, markedly increases the phosphorylation of HSF1 and expression of HSF1 and HSP72 in adipocytes and muscle cells; protects against obesity-induced insulin resistance and orally active; alleviates ventilation-induced diaphragm dysfunction associated with HSP72 induction and PARP-1 inhibition.Diabetes Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsBGP 15 | BGP15
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number66611-37-8
-
Formula Weight351.272
-
Molecular FormulaC14H24Cl2N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 11.33 mg/mL
-
SMILESC1CCN(CC1)CC(CON=C(C2=CN=CC=C2)N)O.Cl.Cl
-
Chemical Name3-Pyridinecarboximidamide, N-[2-hydroxy-3-(1-piperidinyl)propoxy]-, hydrochloride (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Salah H, et al. Sci Transl Med. 2016 Aug 3;8(350):350ra103.
2. Chung J, et al. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1739-44.
3. Racz I, et al. Biochem Pharmacol. 2002 Mar 15;63(6):1099-111.
4. Kardon T, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1023-8.
molnova catalog
related products
-
OUL232
OUL232 is a potent single ARTs PARP7, PARP10, PARP11, PARP12, PARP14 and PARP15 inhibitor for cancer and tumour research.
-
TIQ-A
TIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.
-
E7449
E7449 (2X-121) is a potent, orally bioavailable, brain penetrable dual inhibitor of PARP1/2 and TNKS1/2 with IC50 of 2.0/1.0 nM (PARP1/2), 50-100 nM (TNKS1/2).
